The book is currently out of stock
Parameters
More about the book
This volume looks at 311C90, a new 5-HT1D receptor agonist, which is in development for the acute treatment of migraine. It examines the clinical effectiveness, safety and future prospects of this agent.
Book purchase
311C90: further advances in the pathogenesis and acute treatment of migraine, John Edmeads
- Language
- Released
- 1996
We’ll email you as soon as we track it down.
Payment methods
We’re missing your review here.